[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![megharaj_g_k Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1803802590167404544.png) Megharaj Kavalur [@megharaj_g_k](/creator/twitter/megharaj_g_k) on x 3330 followers
Created: 2025-07-26 11:28:42 UTC

Sahajanand Medical Technologies (SMT)
Surat-based Global Medical Device Manufacturer
Focus: Vascular Intervention & Structural Heart

● DRHP Filed with SEBI
▪︎ IPO Size: 2,76,44,231 Shares (Full OFS)
▪︎ FV: ₹1 | Retail: XX% | Employee Quota ●

● Financials
▪︎ FY23: ₹803.3 Cr Revenue | ₹11.9 Cr PAT
▪︎ FY24: ₹908.6 Cr Revenue | ₹7.3 Cr Loss
▪︎ FY25: ₹1,036 Cr Revenue | ₹25.2 Cr PAT

● Estimated IPO Size
▪︎ ₹1,500–2,000 Cr at ₹6,000–8,000 Cr Valuation

● Market Presence
▪︎ XX% Share in Drug-Eluting Stents (India)
▪︎ Top X in Germany, Spain, Poland, Brazil

● R&D Strength
▪︎ XXX Global Patents
▪︎ XX Patent Applications in Pipeline

● Lead Managers
Motilal Oswal | Avendus Capital | Nuvama | HSBC

● Product Portfolio
Stents, Balloons, TAVI, Occluders, DCBs, Renal Stents

#ipo #stockmarket

![](https://pbs.twimg.com/media/Gwx7ncybAAAf1s5.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949069361316274630/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[ipo](/topic/ipo)
[smt](/topic/smt)

[Post Link](https://x.com/megharaj_g_k/status/1949069361316274630)